Risks of serious liver injury, herpes meningoencephalitis with Gilenya

This is a preview of subscription content, access via your institution.

Reference

  1. Medicines and Healthcare products Regulatory Agency (UK). Fingolimod (Gilenya): updated advice about the risks of serious liver injury and herpes meningoencephalitis. Internet Document : 7 Jan 2021. Available from: URL: https://www.gov.uk/drug-safety-update/fingolimod-gilenyav-updated-advice-about-the-risks-of-serious-liver-injury-and-herpes-meningoencephalitis

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Risks of serious liver injury, herpes meningoencephalitis with Gilenya. Reactions Weekly 1839, 9 (2021). https://doi.org/10.1007/s40278-021-89847-8

Download citation